The number of lung cancer cases in people who have never smoked is increasing. The disease is different from lung cancer ...

For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope. Exciting new research ...

New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and patients crucial ...

Survival outcomes favored the higher dose: more than 93% of patients in the 70 Gy group were alive one year after treatment, ...

Doctors at the University of Louisville’s Brown Cancer Center have found that a new cancer treatment is showing promising ...

Dr. Jared Weiss details the importance of continued research into novel therapies for patients with lung cancer.

Non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer cases and remains a leading cause of cancer ...

More than one quarter of the medcines cleared by the FDA’s main review office since 2015 have been cancer drugs, a tally that ...

Doctors and researchers are constantly working to find new ways to catch cancers earlier, and help you beat it if it happens.

The MHRA has approved aumolertinib for adult patients with non-small cell lung cancer (NSCLC), following a groundbreaking ...

Study examines treatment options for those with operable non-small cell lung cancer, the leading cause of cancer deaths ...

A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, ...